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Abstract. HL 60 cells were subcloned into variants 
with different sensitivities to the differentiation-induc- 
ing effect of 1,25 dihydroxyvitamin  D3 (I,25(OH)2D3), 
as shown by increased oxidative and phagocytic activ- 
ity and the appearance of cytoplasmic a-naphthyl bu- 
tyrate esterase. Brief treatment (4 h) with 1,25(OH)2D3 
or 5-azacytidine (5-Aza CR) of sensitive sublines in- 
duced monocytic differentiation in a fraction of 
treated cells. The phenotypic differentiation induced 
by 1,25(OH)2D3 was preceded by altered expression of 
oncogenes c-myc and c-fos, but not of c-Ha-ras or of 
the constitutively expressed p72 gene. Treatment with 
5-Aza CR had similar effects but in addition increased 
the rate of transcription of the c-Ha-ras oncogene. In 
partially resistant sublines exposure to 1,25(OH)2D3 or 
5-Aza CR resulted in changes in the levels of c-myc 
and c-fos mRNA, but the expression of c-Ha-ras gene 
did not correlate with the phenotypic differentiation. 
When induction of differentiation in responsive cells 
was delayed by cycloheximide, a temporal correlation 
could be made between changes in the expression of 
the c-myc gene and differentiation. These results sug- 
gest that a reduction of the elevated levels of c-myc 
gene transcription in HL 60 cells is required for the 
initiation of monocytic differentiation, that the induc- 
tion of c-fos gene expression is an early step in this 
process, and that the transient increase in the expres- 
sion of c-Ha-ras gene by 5-Aza CR is not related to 
differentiation. 
T 
hE oncogene c-myc has been implicated in the control 
of cell replication (Kelly et al.,  1983; Campisi et al., 
1984;  Kaczmarek  et  al., 1985), and  its  abnormal 
expression may account  for the  aberrant  growth and poor 
differentiation of  some tumor cells (Dalla Favera et al., 1982a; 
Taub et al., 1982; Alitalo et al., 1983; Klein, 1983; Little et 
al., 1983). However, the abnormal expression of other genes 
may also be necessary to permit the progression of the trans- 
formed cells to the expression of the fully malignant pheno- 
type (Diamond et al., 1983; Land et al., 1983; Ruley, 1983). 
The reversal of the neoplastic phenotype through differen- 
tiation  is sometimes possible and occurs spontaneously in 
some  human tumors,  most  strikingly in teratocarcinomas 
(Pierce and Wallace, 1971) and neuroblastomas (e.g., Knud- 
son and Meadows, 1980). Human leukemic ceils in culture 
have also provided interesting models of cell differentiation. 
For instance, HL 60 cells, derived from a patient with pro- 
myelocytic leukemia (Collins et al., 1977), can be induced to 
differentiate towards granulocytes (Collins et  al., 1978) or 
monocytes (Rovera et al., 1979) by a variety of  agents, though 
these chemically induced mature forms do not completely 
resemble the normal end cells  of  those pathways of  maturation 
(Newburger et al., 1979; Pessano et al., 1983; Koeffler et al., 
1984). HL 60 cells have a markedly amplified c-myc oncogene 
(Collins and Groudine,  1982; Dalla Favera et al., 1982b), 
which is overexpressed as compared with the oncogene in 
normal myeloid cells, but its expression is reduced by agents 
that induce granulocytic or monocytic differentiation of  these 
ceils (Westin et at.,  1982; Reitsma et at., 1983; Grosso and 
Pitot, 1984, 1985). It would appear that high or inappropriate 
expression of the c-myc gene prevents the cell's entry into a 
differentiation program, but it has been argued that the de- 
clining expression of c-myc is a consequence, rather than a 
cause, of differentiation. Gonda and Metcalf (1984) observed 
that transcription of c-myc RNA decreases only at late stages 
of differentiation of murine myeloid leukemic cells, and Fil- 
mus  and  Buick  (1985) concluded  that changes in  c-myc 
expression in HL 60 cells induced with dimethylsulfoxide can 
be attributed primarily to cell differentiation. 
There are conflicting reports on the kinetics of induction 
of c-fos gene expression in leukemic cells. An early increase 
in the expression of c-fos mRNA was noted in phorbol-12- 
myristate-  13-acetate (TPA)~-induced (Mitchell et al., 1985), 
1.  Abbreviations used in this paper: 5-Aza CR, 5-azacytidine; dThd, thymidine; 
NSE,  nonspecific esterase; poly A  ÷, polyadenylated;  TPA, phorbol-12-myris- 
tate-  13-acetate; 1,25(OH)2D3, I ct,25 dihydroxyvitamin D3. 
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monocytic differentiation (Muller et al.,  1985). On the other 
hand,  experiments with  the granulocyte-colony stimulating 
factor in the presence of actinomycin D (Gonda and Metcalf, 
1984), or with TPA (Muller et al.,  1984), led to the suggestion 
that the expression of the c-fos gene in mononuclear phago- 
cytes is restricted to late stages  of differentiation. These re- 
ports, therefore, raise questions regarding both the rapidity 
and the significance of the induction of c-fos gene to mono- 
cytic differentiation. 
We  have  recently described a  procedure that  permits a 
closer analysis of the events associated with the initiation of 
the  monocytic differentiation  pathway  (Studzinski  et  al., 
1985a). A short exposure to the inducer in the absence of a 
serum  supplement  in  the nutrient  medium  transiently de- 
creases the steady state level of c-myc mRNA and is followed 
by phenotypically recognizable differentiation of a significant 
proportion  of treated  cells,  at  a  time  c-myc  mRNA  has 
returned to the pretreatment levels (Studzinski et al.,  1985a). 
We now report a more detailed comparison of the kinetics of 
changes in the transcription rates of oncogenes c-myc and c- 
fos produced by treatment with two inducers of monocytic 
differentiation of HL 60 cells; a comparison of these changes 
with the expression of c-Ha-ras gene, since the ras family of 
genes is known to be related to cell proliferation rather than 
differentiation (e.g., Campisi et al.,  1984); and the relationship 
of these changes to the subsequent appearance of the pheno- 
typically more mature cells. 
Materials and Methods 
Cell Culture 
The original stock cultures  were HL 60 cells obtained  from Dr. G. Rovera. 
These cells were subeloned in semisolid agar essentially as described by Boyd 
and  Metcalf  (1984),  and  variants  with  differing responses  to  induction  of 
differentiation  by 1,25(OH)2D3 were selected and propagated in suspension as 
described (Studzinski et al.,  1985a). As before, untreated cultures had viability 
of >90% (trypan blue exclusion) and a doubling time of 24-36 h. 
Assessment of the Differentiation State 
The determination  of markers of monocytic differentiation has been described 
in detail (Studzinski et al., 1985a). The time course of  changes in the phenotype 
indicative of differentiation was routinely followed by Giemsa staining and by 
cytochemical determination  of a-naphthyl butyrate esterase (nonspecific ester- 
ase, NSE) activity (Yam et al., 1971). Two observers enumerated the proportion 
of  NSE-positive ceils on coded slides. These indices of  differentiation correlated 
well with other markers  for monocytes, such as reduction  of nitro blue tetra- 
zolium, phagocytosis, and adherence to substratum (Studzinski et al., 1985a). 
Determination of  DN.4 Synthesis 
The overall rate  of DNA synthesis was determined  by exposing aliquots  of 
control and drug-treated cultures for I h to 5 uCi/ml of [3H]thymidine (dThd) 
(methyl-3H, specific activity 62 Ci/mmol, ICN Biomedicals Inc., Irvine, CA). 
The samples were centrifuged and washed four times with phosphate-buffered 
saline, then three  times with  I ml ice-cold 5% trichloracetic  acid. The acid- 
insoluble  precipitate  was washed  three  times  with  1 ml  95%  ethanol  and 
dissolved in 200 ul 0.1 N NaOH. A 50-td aliquot of this solution was added to 
5 ml Biofluor (New England Nuclear, Boston, MA), and the radioactivity was 
determined in a Beckman LS-300 liquid scintillation counter (Beckman Instru- 
ments Inc., Palo Alto, CA). 
Hybridization  Probes 
pMyc 7.4, a gift from Dr. G. Rovera, is a 1.2-kb cDNA fragment of the second 
and third exons of the c-myc gene inserted at the Pst I site of pBR322 (Watt et 
al., 1983). Plasmid pc-los (human) containing an 8.8-kb DNA fragment inserted 
into the EcoR  I site of pBR322 (Van Straaten  et aL,  1983) was cleaved to 
obtain the 2.7-kb Xho l-Neo I restriction fragment for use as a probe (Mitchell 
et al., 1985). Plasmid pc-ras contains a Barn HI 6.2-kb fragment ofT24 DNA, 
a gift from Dr.  M. Wigler (Taparowsky et at.,  1982). Probe p72 is a cloned 
DNA fragment from the human tumor cell line A-549 ligated to the pML-TK- 
Bgi II plasmid  by Dr. A. Pater.  It contains an expressed portion of human 
tumor cell genome (Pater  and Pater,  1984). The plasmids were grown and 
purified, and the probes were excised with the appropriate restriction enzymes, 
electroeluted from preparative  1% agarose gels using a unidirectional electroe- 
luter (I.B.I. Inc., New Haven,  CT), and labeled in vitro by nick translation. 
These procedures  are described by Maniatis  et al. (1982). Typically,  10~-108 
cpm/ng DNA was prepared for use as a hybridization probe. 
Measurement of Cellular mRNA Content 
For determination  of RNA  transcript  levels by dot-blot  hybridization  total 
cellular RNA was extracted using the guanidinium  isothiocyanate/hot  phenol 
method, its integrity was checked by electrophoresis in a  1% agarose minigel, 
and polyadenylated  (poly A  ÷) RNA was obtained  using batch absorption  to 
oligo(dT) cellulose (Maniatis  et  al., 1982), quantitated  by  hybridization  to 
13H]-poly U (Bantle et al.,  1976), and blotted onto Biotrans nylon membrane 
(ICN Biomedicals Inc.) at several dilutions according to the protocol supplied 
by the manufacturer.  In preliminary  experiments the amounts of RNA were 
determined  that fall on the linear portion of the dose-density curve, after a 
standard autoradiographic exposure, and quantitation  of blot intensity using a 
scanning densitometer, on two separate autoradiograms of each transfer. 
Northern transfer ofpoly A  ÷ RNA onto the nylon membrane was performed 
after the RNA was denatured  by being heated at 65"C for 5 rain in  10 mM 
sodium  phosphate  (pH 6.5), 50%  formamide,  2.2 M formaldehyde, 0.5 mM 
EDTA, and fractionated by electrophoresis in 1.0% agarose gel containing  1.1 
M formaldehyde,  l0 mM sodium phosphate at pH 6.5 (Meinkoth  and Wahl, 
1984). The blots were air dried, baked for 3-4 h at 80"C, and hybridized for 
~20 h at 45"C to 1 x  l0  s cpm of nick-translated probes (specific activity l0  T- 
10  s cpm/#g DNA)  per  1 ml of the hybridization  buffer (0.05 ml/cm  2) and 
thoroughly washed as described previously (Studzinski et al., 1985a). Routinely, 
c-Ha-ras was hybridized along with either c-myc or c-fos mRNA for a direct 
comparison  of cellular mRNA levels, which obviated possible RNA transfer 
problems. 
Dot-blots  performed  on total  cellular  RNA gave results similar  to those 
obtained  with  poly A  ÷ RNA,  but these  were  not used  in the experiments 
reported here. There was in general good agreement between results obtained 
with dot-blots and Northern transfers, and although some variation on individ- 
ual blots was occasionally seen, the trends shown in the summaries of the data 
were evident in each experiment. 
Nuclear Transcription Assay 
RNA chain elongation in isolated nuclei (McKnight and Palmiter,  1979) was 
performed by the method described by Sheffery et al. (1984) with the following 
modifications.  Nuclei from 5 x  107 cells were isolated (Hallick and Namba, 
1974) and counted in a hemocytometer.  2 x  107 nuclei were incubated for 20 
min at 37"C in a reaction mixture containing  1 mM ATP, 0.25 mM GTP, 0.25 
mM CTP,  and  100 ~tCi (33 nM) [~-~2p]-UTP (3,000 Ci/mmol sp act). The 
labeled  RNA  was extracted,  and  equal  amounts of acid-precipitable  RNA 
radioactivity  (4  x  106 cpm) were used to hydridize  10 ug DNA from each 
probe, excised from plasmids, and blotted on Biotrans nylon membrane. The 
filters were thoroughly washed as described and exposed to X-AR2 x-ray films 
(Eastman  Kodak Co., Rochester, NY) with an intensifying screen for -72 h. 
Comparisons  of blot  intensity  could  be made  only within  each experiment, 
since the duration  of  exposure varied for the films shown in Figs. 5, 9, and 10. 
Background controls were performed by hybridization  of the nuclear  run off 
to filters containing  immobilized  pBR322  DNA and showed  no significant 
hybridization, and a-amanitin at 2 ug/ml added to the transcription  reaction 
abolished the incorporation  of the precursors into all mRNAs studied. 
Materials 
1,25(OH)2D3 was  a  generous  gift  from  Dr.  Milan  Uskokovic,  Hoffmann- 
LaRoche, Nutley, NJ. 5-Azacytidine (5-Aza CR) and other biochemicals were 
obtained from Sigma Chemical Co., St. Louis, MO. 
1,25(OH)2D3 and 5-Aza CR were used at concentrations that in preliminary 
experiments were shown to inhibit the DNA synthesis of ilL 60 cells to -20% 
of the control level, after a 4-h exposure of the cells to the compound. 
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Sequential Changes  in Oncogene Expression  in 
Subclones of  ilL 60 Cells Responsive  and Resistant to 
the Induction of  Monocytic Differentiation 
We chose 1,25(OH)2D3  as the primary tool for examining the 
relationship between changes in the expression of c-myc and 
c-fos genes  and  monocytic differentiation  of HL  60  cells 
because  of its  low  cytotoxicity and  its  effectiveness  as  an 
inducer  of transient  phenotypic changes after brief contact 
with these cells (Studzinski et al., 1985a). Our previous studies 
have  also  shown  that  HL 60  cells  obtained  from  different 
sources respond to the inducers of  differentiation in a variable 
manner. We have therefore subcloned cultures of HL 60 cells 
in soft agar and selected a  number of clones with a range of 
susceptibility  to  the  differentiation-inducing  activity  of 
1,25(OH)2D3,  including  several  sublines  that  do  not  show 
significant evidence of differentiation within 72 h after a 4-h 
pulse with  1,25(OH)2D3  (e.g.,  clones HL 60-R3 and HL 60- 
R4), and some with intermediate  sensitivity to  1,25(OH)2D3 
(e.g., clones HL 60-R3ZI and HL 60-AB3), as judged by NSE 
activity, nitro blue tetrazolium reduction, phagocytosis, and 
the adherence to the substratum.  Sublines that differentiated 
in  response  to this  induction  regimen  (e.g.,  clones  HL 60- 
R2AB2  and  HL 60-R5AB2) showed  an  almost  immediate 
decrease in c-myc RNA concentration (Fig.  1), followed rap- 
idly by an activation of the expression of c-fos gene (Fig. 2). 
There were  no detectable  changes in  the  levels of c-Ha-ras 
mRNA (Fig.  3), or gene p72 mRNA and the overall rate of 
RNA synthesis (data not shown). In contrast, in sublines of 
HL 60 cells (e.g.,  clone HL 60-R4) that failed to differentiate 
in response to  1,25(OH)2D3,  the level of the c-myc mRNA 
remained essentially unchanged, and c-fos mRNA increased 
less than in cells that differentiated (Fig. 4 and Table I). More 
detailed results for three other sublines tested are summarized 
in Table II. It may be noted that DNA synthesis was inhibited 
in resistant sublines exposed to 1,25(OH)2D3,  which, together 
with transcription of c-fos gene, indicated that a failure of the 
compound to enter the cells was not the reason for the reduced 
ability of these cells to differentiate. 
Brief exposure of several of the HL 60 subtines to 5 x  10  -6 
M  5-Aza  CR,  a  concentration  that  produced  a  transient 
inhibition  of DNA  synthesis,  showed  that  this  nucleoside 
analogue also induces monocytic differentiation.  Sublines of 
HL 60 cells partially or fully resistant to  1,25(OH)2D3  were 
also partially resistant to the induction of differentiation by 
5-Aza CR  (Fig.  4  and  Table  I).  Again,  there  was  a  good 
correlation between the degree of inhibition of c-myc expres- 
sion by 5-Aza CR and the extent of  subsequent differentiation, 
but such a relationship between the increased transcription of 
the  c-Ha-ras  gene  and  phenotypic  differentiation  was  not 
evident. Expression of c-fos gene was increased less by 5-Aza 
CR in sublines with reduced proportion of  differentiated cells, 
but the correlation with the expression of phenotypic markers 
of differentiation was less clear than for c-myc, suggesting that 
Figure 1. Dot-blot analysis of the levels of c-myc mRNA during and 
after a 4-h exposure of  ilL 60-R2AB2 cells to 4 x  10  -7 M 1,25(OH)2D3 
(rows marked D) and in untreated cultures (C). Three concentrations 
of poly A  ÷ RNA (25, 5, and 1 t~g per well) were dot-blotted  in rows 
marked  by  the  duration  (in  hours)  of the  experiment  from the 
initiation  of the exposure  to 1,25(OH)2D3. To, time  of addition  of 
1,25(OH)2D3. 
Figure 2. A dot-blot analysis of c-fos mRNA annotated as Fig. 1. In 
addition to untreated  (C) and 4 x  10  -7 M  1,25(OH)2D3-treated (D) 
groups, poly A  + RNA was extracted  from HL 60-R2AB2 cultures 
treated for 4 h with 7.1 x  10  -5 M (20 gg/ml) cycloheximide (CC) or 
4 x  10  -7 M 1,25(OH)2D3  together with 7.1 x  10  -5 M cycloheximide 
(DC). The blots D-4 h and D-8 h were more evident on the original 
autoradiogram. 
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from the 1,25(OH)2D3-resistant subline HL 60-R3. The RNA blotted 
exactly as in the experiment shown in Fig.  1. 
the activation of c-fos gene is a  necessary but an insufficient 
step for differentiation (Fig. 4). 
Results shown in Table II also indicate that in responsive 
cells the inhibition of c-myc gene expression by 1,25(OH)2D3 
can be detected before the evidence of activation of the c-fos 
gene transcription, and,  more strikingly, that both the inhi- 
bition of the c-myc gene and the NSE index of differentiation 
are transient, whereas the expression of the c-fos gene contin- 
ues long after the inducer is removed. The increased levels of 
c-fos mRNA precede the appearance of NSE activity and peak 
a  little earlier but persist longer.  In one  responsive subline 
(HL 60-R3ZI  cells, Table II) tested at 90 h, when  no mor- 
phological  or  cytochemical  evidence  of differentiation  re- 
mained after a  4-h exposure to  1,25(OH)2D3,  the level of c- 
fos mRNA  was  still greatly elevated as compared with  the 
level in unindueed HL 60 cells. 
Since cellular levels of mRNA are subject to changes due 
to altered degradative as well as transcriptional activity (Dani 
et al., 1984,  1985), we have confirmed that changes in onco- 
gene mRNA levels are due to altered rates of transcription, 
using nuclei isolated from  HL 60-R2AB2  cells treated with 
1,25(OH)2D3  (Fig. 5).  The data show an  early inhibition of 
transcription of the c-myc gene (~ 1 h) that is reversed shortly 
after the inducer is removed, an activation of the c-fos gene 
(at 2  h) that persists for the duration of this experiment, but 
no appreciable change in the transcriptional rates of genes c- 
Ha-ras and p72, a gene constitutively expressed in HL 60 cells 
(Pater and Pater,  1984). 
Monocytic Differentiation  Induced by 1,25(OH)2D3 Is 
Delayed by Cycloheximide in Parallel with Its Effects 
on c-myc mRNA Levels 
The link between changes in oncogene expression and phe- 
notypic  changes  in  HL  60  cells  was  further  examined  in 
Figure 4. Northern blot analysis of 
oncogene mRNA levels after a 4-h 
exposure to  either  4  x  10  -7  M 
1,25(OH)2D3 or 5 x  10  -6 M 5-Aza 
CR in three sublines of ilL 60 cells 
with different sensitivities  to  the 
differentiation-inducing effects  of 
1,25(OH)2D3. (A) 10 ttg RNA was 
applied  to each lane. The Northern 
blot  was  hybridized  simultane- 
ously  to  c-myc  and  c-Ha-ras 
probes. Note separation of the two 
c-myc transcripts (2.4 and 2.2 kb). 
The c-Ha-ms probe had low [32p]_ 
specific activity in this hybridiza- 
tion,  but  the  c-Ha-ras transcript 
(1.4  kb) was  more dearly visual- 
ized  after  a  longer  autoradi- 
ographic  exposure  (not  shown) 
and served as an internal control 
for gel loading and the RNA trans- 
fer. (B) Northern blot hybridized 
to c-fos (2.2 kb) and c-Ha-ras (1.4 
kb) probes. The lanes for both A 
and B are indicated as follows: M, size markers (Hind III digest of lambda phage); C 0, poly A  + RNA from untreated cells; D, poly A  ÷ RNA 
from  1,25(OH)2D3-treated cells; A, poly  A  + RNA from 5-Aza CR-treated ceils. Designations 4 and 8 refer to the number of hours from the 
initiation of the experiment. 
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Shown in Fig. 4, and the Subsequent Appearance of NSE Activity 
HL 60-R2 AB2 cells  HL 60-R2 AB3 cells  HL 60-R4 cells 
Inducer  Time  c-myc*  c-fos:  NSE  °  c-myc  c-fos  NSE  c-myc  c-fos  NSE 
h 
1,25(OH)2D3 (1 x  10  -7 M)  4  6.3  9.4  22  3.7  89  2.9 
8  6.1  17.8  13.1  10.8  88  6.5 
30  39  10  1 
5-Aza CR (5 x  10  -6 M)  4  5.0  4.7  23  4.3  7.6  3.2 
8  2.4  9.7  5.1  5.6  6.8  5.3 
30  45  12  10 
* Percent of control at 0 h. The mean values of two experiments are presented. To, addition of 1,25(OH)2D3  or 5-Aza CR. 
* Densitometer readings in arbitrary units. 
o Percentage of cells positive for NSE activity. 
Table H. Levels of c-myc, c-fos, and [3H]-dThd Incorporation in Sublines of  ilL 60 Cells Exposed to 4 x  10  -7 M 1,25(OH)zD3 
for 4 h and Allowed to Differentiate in Normal Medium 
Time (h) 
0  1  2  4  6  8  10  12  14  18  24  30  50  90 
HL 60-R2AB2 
c-myc*  100  66  44  2.5  2.0  1.2  23  49  75  116  114  106 
c-fos  ~  ND  ND  20  44  46  45  44  35  34 
dThd incorporation*  100  34  80 
NSE  ~  5  5  6  21  24  25  28  38  51  26 
HL 60-R3Z 1 
c-myc  100  3.1  3.1  9  31  65  87  106 
c-fos  ND  ND  10  16  25  38  41  40  28  20 
dThd incorporation  100  12  81  93 
NSE  1  0  1  10  15  21  29  19  5 
HL 60-R3 
c-myc  100  109  92  103  98 
c-fos  3  2.5  6  2  2 
dThd incorporation  100  62  62  60  75  78  77  93  96 
NSE  0  0  0  0  1  0  1  0 
Mean values of two separate experiments are shown. Oncogene mRNA levels were determined by serial dot-blots. To, addition of 1,25(OH)2D3  or 5-Aza CR. ND, 
not detected. 
* Percent of control at 0 time (addition of 1,25(OH)2D3). 
* Densitometer deflection in arbitrary units. The background control (pBR322) had no detectable absorption. 
0 Percentage of the cells positive for NSE activity. 
experiments in which the effects of the inducer were modu- 
lated by a  simultaneous addition of cycloheximide at a  con- 
centration that inhibits protein synthesis to ~5% of the con- 
trol rate after 4 h of exposure (Fig. 6). Comparison of control 
samples in  Fig. 6,  lanes B-D with samples from cyclohexi- 
mide-treated cells in  lanes H-L, and samples in lanes E-G 
(1,25(OH)2D3) with lanes M-Q (l,25(OH)2D3 and cyclohexi- 
mide), shows that the addition of cycloheximide to the cul- 
tures increased the levels of both c-myc and c-Ha-ras mRNA. 
The increases in these mRNAs were most marked aiter 4  h 
of exposure to  cycloheximide, when  the  drug  was  washed 
away,  and  control values were  reached  at  ~ 12-18  h,  when 
the rate of protein synthesis was -60%  of the control. Inhi- 
bition of protein synthesis is known to stabilize c-myc mRNA 
(Kelly et al., 1983; Dani et al., 1984). A rather similar increase 
in c-fos mRNA is illustrated in Figs. 2  and 7.  In Fig. 7, the 
levels of c-los mRNA that were not detectable in untreated 
cells (lanes B-D) became recognizable after 4 h  of cyclohexi- 
mide treatment  (lane H),  and  the  blots were  more  intense 
after the addition of cycloheximide in both Figs. 2 and 7. 
In addition to  such  stabilization of oncogene  mRNA by 
cycloheximide, these experiments demonstrate that cyclohex- 
imide  delays the  recovery  from  the  1,25(OH)2D3-induced 
decrease  in  c-myc  mRNA  levels  (Fig.  6,  lanes M-Q),  as 
previously shown for TPA-plus-cycloheximide-treated  HL 60 
cells  (Mitchell  et  al.,  1985).  Additional experiments  were 
carried out  in  which  oncogene  mRNA  was  quantitated  by 
other Northern  and  multiple dot-blots, and the  phenotypic 
evidence of differentiation was monitored in parallel. These 
data are  summarized  in  Fig.  8,  which  shows  the temporal 
relationship between the reduced cellular levels of the c-myc 
transcripts and the subsequent phenotypic differentiation, and 
the delay in both parameters due to the cycloheximide treat- 
ment. 
The  cycloheximide-induced delay in  the  inhibition of c- 
myc gene transcription was confirmed by the determination 
of nuclear transcription rates on oncogene mRNA in HL 60- 
R2AB2 cells treated with cycloheximide alone or with cyclo- 
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tracted  from  an  isolated  nuclei 
transcription  system  (HL  60 
R2AB2  ceils) and  hybridized  to 
probes  immobilized  on  Biotrans 
nylon filters for c-myc (M), c-fos 
(F), c-Ha-ras (R), and p72 (P). The 
time at which nuclei were isolated 
after the addition of the inducer (4 
X  10  -7  M  1,25(OH)2D3) is indi- 
cated in hours  for untreated  (C) 
and  induced  (D)  cultures.  The 
transcription of c-Ha-ras and p72 
genes is essentially unchanged, and 
these blots provide controls for the 
upper panels. 
Figure 6.  Northern  blot analysis of the 
time sequence of the effects of a 4-h ex- 
posure of ilL 60-R5AB2 cells to 4 x  10  -~ 
M  1,25(OH)2D3 and/or 7.1  x  10  -5  M 
cycloheximide on cellular poly A  + RNA 
transcripts  that  hybridize to  the  c-myc 
probe (transcript size 2.4 and 2.2 kb) and 
to a c-Ha-ras probe (1.4 kb transcript). 10 
~g poly A  + RNA was applied to each lane. 
Lane A,  Hind III digest of 32p-labeled 
lambda phage, size markers. Lanes B-D, 
RNA from untreated  cultures, extracted 
at 4 h (lane B), 8 h (lane C), and  12 h 
(lane D) from the initiation of the experiment. Lanes E-G, cultures treated with 1,25(OH)2D3 for 4 h, mRNA extracted at 4 h (lane E), 8 h 
(lane F), and 12 h (lane G). Lanes H-L, cultures exposed to cycloheximide for 4 h, mRNA extracted at 4 h (lane H), 8 h (lane I), 12 h (lane 
J),  18 h (lane K), and 24 h (lane L). Lanes M-Q, cultures treated with 1,25(OH)2D3 in the presence of cycloheximide for 4 h. RNA extracted 
at 4 h (lane M), 8 h (lane N),  12 h (lane O), 18 h (lane P), and 24 h (lane Q). 
Figure  7.  Northern  blot  analysis  of 
mRNA transcripts from c-fos (2.2 kb) and 
c-Ha-ras (1.4 kb) genes, performed in par- 
alld with the experiment shown in Fig. 6. 
The RNA samples were electrophoresed 
and annotated on the autoradiogram ex- 
actly as shown for Fig. 6. 
heximide plus  1,25(OH)2D3  (Fig.  9).  Cycloheximide alone 
had no detectable effect on the transcriptional rates, whereas 
the  transient inhibition of transcription of c-myc gene by 
1,25(OH)2D3  shown in Fig.  5  (2-10  h)  was  delayed when 
cycloheximide was  added  to  1,25(OH)2D3  during the  4-h 
induction period. In contrast, nuclear transcription of c-fos 
gene was not delayed by the exposure to cycloheximide and 
1,25(OH)2D3  (compare  Figs.  5  and  9).  These  data,  taken 
together, are consistent  with the hypothesis that the inhibition 
of the transcription of c-myc gene is the signal that initiates a 
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cells, but not with the view that increased transcription  of c- 
fos plays such a role. 
Cycloheximide Does Not Modulate the Induction of 
Monocytic Differentiation or the Inhibition of c-myc 
Gene Transcription  by 5-Aza CR 
It is possible to argue that the delay in phenotypic differentia- 
tion produced by the addition of cycloheximide to the induc- 
tion system was due to a slower progression of the cells along 
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Figure 8. Modification  by cycloheximide (CHX) of the time relation- 
ships between the  1,25(OH)2D3-induced events: (A) the reduction in 
cellular c-myc mRNA levels; (B) the increased levels of c-fos mRNA; 
(C) the phenotypic differentiation  assessed by NSE activity. The data 
were obtained in three separate experiments, analyzed by dot-blots at 
each time point (mean values were used to construct the graphs), and 
confirmed at selected time points by Northern blot transfers, examples 
of  which  are  shown  in  Figs.  6  and  7.  e,  untreated  cells. O, 
1,25(OH)2D3, 0.4/~m.  A, CHX, 20/zg/ml. &, 1,25(OH)2D3 + CHX. 
the  differentiation  pathway  whereas  protein  synthesis  was 
impaired  by the  residual  effects of cycloheximide exposure. 
That this was not the case was shown by experiments carded 
out as described in the preceding section but in which 5-Aza 
CR was substituted  for  1,25(OH)2D3  (Figs.  10-12).  Nuclear 
transcription assays indicated that changes in the transcription 
rates of oncogenes c-myc, c-fos, and c-Ha-ras produced by 5- 
Aza  CR  were  not  altered  by  a  simultaneous  exposure  of 
differentiation-sensitive  cells to cycloheximide (Fig.  10).  Al- 
though  cycloheximide  increased  mRNA  stability,  as  shown 
on  the  Northern  blot (Fig.  11)  and  summarized  in Fig.  12, 
when cellular protein synthesis resumed (at ~ 12 h) the levels 
ofc-myc and c-fos mRNA in cycloheximide-exposed cultures 
became identical to the levels found in cells induced with 5- 
Aza CR alone.  Significantly,  5-Aza CR-induced  phenotypic 
differentiation was not delayed by the addition  of cyclohexi- 
mide,  suggesting that a  fixed interval of time separates inhi- 
bition ofc-myc gene transcription and phenotypic differentia- 
tion. 
An  increase  in  the  expression  of c-Ha-ras gene  was  also 
noted after exposure to 5-Aza CR (Fig.  10, lanes 4 and 8, and 
Fig. 11, lanes F-H). Since this was not observed when HL 60 
cells were induced to differentiate with 1,25(OHhD3 or several 
other inducers of HL 60 cell differentiation (data in prepara- 
tion), it does not appear to be a differentiation-related event. 
Discussion 
The experiments were designed to determine to what extent 
changes in c-myc and c-fos gene expression fit the role of the 
signal that initiates monocytic differentiation of HL 60 cells. 
Our  experimental  system  permits  examination  of cellular 
changes in the absence of the chemical inducer. Brief exposure 
of sensitive cells to the  inducing  agent inhibits  c-myc tran- 
scription within  1 h (Fig.  1), followed shortly by induction of 
c-fos  expression  and  a  delayed  appearance  of  markers  of 
phenotypic differentiation (Figs. 8 and  12). The recovery of a 
high rate ofc-myc transcription after removal of 1,25(OHhD3 
has been noted (Reitsma et al., 1983; Studzinski et al., 1985a), 
but we show here more precise kinetics of this recovery, and 
a  constant  relationship  between these events (the inhibition 
and the recovery of transcription  of the c-myc gene) and the 
expression and disappearance  of the phenotypic differentia- 
tion  markers.  The appearance  of maturation  characteristics 
Figure 9. Dot-blot analysis of 32p-labeled 
RNA transcribed  in nuclei isolated from 
HL60-R2AB2 cells exposed to 7.1  x  10-' 
M  cycloheximide (CC) or  4  x  10  -7  M 
1,25(OH)2D3  (DC)  for  4  h.  l0  #g  myc 
(M), fos (F) and c-Ha-ms (R) DNA was 
blotted on the membrane and hybridized 
to 4  x  10  6 cpm of acid-precipitable  a2p_ 
labeled  RNA  as  described  in  Materials 
and Methods. 
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levels indicates that high levels of transcription of the c-myc 
gene do not interfere with the concurrent phenotypic differ- 
entiation  of HL 60  cells.  However,  the  transient  nature  of 
such differentiation shows that the downregulation of c-myc 
transcription  must be maintained  for the progression of the 
process. The presence of a constant interval of ~24 h between 
the decrease in c-myc mRNA levels and the appearance  of 
differentiation markers suggests that other genes are switched 
on and link the original signal to the recognizable phenotypic 
changes. 
There are no previous reports of induction of c-fos gene by 
1,25(OH)2D3 or 5-Aza CR. Several groups studied its induc- 
tion in HL 60 cells by TPA. Muller et al. (1984) reported that 
c-fos expression is restricted to the late stages of differentia- 
tion, and Mitchell et al. (1985) observed a rapid (20-30 rain) 
increased  in  c-fos mRNA  in  both  U-937  and  HL 60  cells 
exposed to TPA.  This was later confirmed by Muller et al. 
(1985), but this group did not observe a rapid induction ofc- 
fos RNA by 1,25(OH)2D3 and concluded that this phenome- 
non  is  specific  for  treatment  with  TPA.  In  their  system, 
reduced expression  of c-myc RNA was observed later than 
the  rapid  changes  in  c-fos  RNA,  but  changes  in  message 
stability have not been excluded in their experiments. In time 
course  studies  with  1,25(OH)2D3  and  5-Aza CR  presented 
here,  both  cellular  levels  and  transcriptional  rates  of c-fos 
mRNA  increased  2-4  h  after  the  inducer  was  added  and 
remained  elevated  for at  least  90  h  after  the  inducer  was 
Figure  10.  Dot-blot  analysis  of 
transcripts produced by nuclei iso- 
lated  from  HL  60-R2AB2  cells 
treated for 4 h with 5 x  10  -6 M 5- 
Aza CR in the absence (A), or pres- 
ence (AC), of 7.1 x  10  -5 M cyclo- 
heximide, performed as described 
in the legend to Fig. 9. 
Figure 11. Northern blot analysis of the 
time sequence of changes in the levels of 
c-myc (2.4 and 2.2 kb) and c-Ha-ms (1.4 
kb)  transcripts  in  HL  60-R5AB2  cells 
treated for 4 h with 5 x  10  -6 M 5-Aza CR 
and/or 7.1 x  10  -5 cycloheximide (CHX). 
10 #g poly A* RNA was applied to each 
lane.  Lane A, Hind III digest of 32P-la- 
beled lamlxla phage. Lanes B-E, mRNA 
extracted from untreated cells at 4 h (lane 
B), 8 h (lane C), 12 h (lane D), and 24 h 
(lane  E).  Lanes  F-I,  mRNA extracted 
from 5-Aza CR-treated cultures. Lanes J- 
M, cultures exposed to CHX only. Lanes 
N-Q, cultures treated with  5-Aza CR in 
the presence of CHX. In each series the 
time points were 4, 8, 12, and 24 h. 
withdrawn (Table II, Figs. 2, 5, 8-10, and  12). Thus, in our 
system,  the  induction  of the  expression  of c-fos  gene  by 
1,25(OH)zD3 or 5-Aza CR has an intermediate  position in 
the sequence of differentiation-related  events, and the rapid 
increase in c-fos mRNA observed by others may be a peculi- 
arity of TPA. 
The persistence of the increased rates of transcription of c- 
fos gene,  long after the inducer  has been  removed and the 
cultures show decreasing proportions of differentiated  cells, 
has  some  interesting  implications.  First,  it  shows  that  the 
activity  of this  gene  need  not  be  followed  by  phenotypic 
differentiation.  Second, the presence of c-fos mRNA in cul- 
tures that reverted to the undifferentiated phenotype demon- 
strates that the differentiated ceils were not simply lost from 
the  culture  or  totally  outgrown  by  the  cells  that  failed  to 
differentiate,  but rather remained in a phenotypically undif- 
ferentiated form. 
The transient "superinduction" of c-Ha-ras gene by 5-Aza 
CR does not appear to be related to differentiation, since it is 
not observed after the induction of differentiation  by other 
compounds.  This  finding  is  interesting,  however,  because 
activation  of the  related  c-Ki-ras gene  has  been  linked  to 
oncogenic transformation (Taparowsky et al.,  1982) and to 
cell proliferation (e.g.,  Campisi  et al.,  1984),  but not to the 
inhibition of DNA synthesis by a chemotherapeutic drug. 
Only a  few of the events associated with the initiation  of 
differentiation and the selection of a  lineage pathway in HL 
60 cells exposed to antimetabolites  are known at this time, 
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Figure 12. Summary of data obtained in three dot-blot experiments 
and confirmed at selected time points by Northern transfer determi- 
nations of mRNA levels as described in the legend to Fig. 8, but after 
treatment  of HL  60  cells with  5  x  10 -6  M  5-Aza CR  in  place of 
1,25(OH)2D3. e, untreated cells. O, Aza CR, 5 #M. A, CHX, 20 #g/ 
ml. A, Aza CR +  CHX. CHX, cycloheximide. 
but the  following  scenario could serve  as  a  framework for 
further experiments.  Uninduced HL 60 cells have a  highly 
amplified c-myc gene with a correspondingly high expression 
(Westin et al., 1982). If  the excess of  the c-myc protein product 
present in HL 60 cells exerts a strong pressure  on these ceils 
to traverse  rapidly the proliferative  cycle (Kaczmarek et al., 
1985), the failure to pause at various restriction points (Par- 
dee,  1974) may make these cells unresponsive to the signals 
that require a more prolonged residence  in a portion of the 
cell cycle sensitive  to the natural inducers of differentiation. 
Such phase-specific  enhancement of sensitivity  to induction 
occurs in  different  portions  of the  HL  60  cell  cycle  with 
different inducers (Yen and Albright,  1984; Boyd and Metcalf, 
1984; Studzinski et al.,  1985b). Temporary normalization of 
the  elevated  levels  of the  c-myc product in the  cell  by an 
antimetabolite or a hormone would then permit the activation 
of differentiation-related events,  including the transcription 
of c-fos and esterase genes, which result in the appearance of 
the early features of monocytic differentiation. 
Our results suggest that inhibition of the transcription of c- 
myc gene serves as a signal for the initiation of  differentiation 
of HL 60 cells and that inhibition of c-myc gene expression 
must be maintained to ensure a commitment to differentia- 
tion. Increased expression  of the c-fos gene is one of the early 
steps  that lead  to monocytic differentiation and it provides 
the earliest available  evidence of that process but does not fit 
the role of a signal. Involvement of other genes in differentia- 
tion of  leukemic cells, and the mechanisms of  lineage selection 
and progress  along the chosen pathway, remain to be eluci- 
dated. 
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